High Efficiency of Human Normal Immunoglobulin for Intravenous Administration in a Patient with Kawasaki Syndrome Diagnosed in the Later Stages

High Efficiency of Human Normal Immunoglobulin for Intravenous Administration in a Patient with Kawasaki Syndrome Diagnosed in the Later Stages

Blog Article

The article describes a case of late diagnosis of mucocutaneous lymphonodular syndrome (Kawasaki syndrome).At the beginning of the therapy, the child had fever, conjunctivitis, stomatitis, rash, Airliner Model Kits solid swelling of hands and feet, and coronaritis with the development of aneurysms.The article describes the successful use of normal human immunoglobulin for intravenous administration at a dose of 2 g/kg body weight per course in combination with acetylsalicylic acid at the dose of 80 mg/kg per day.

After 3 days of treatment, the rash disappeared; limb swelling and symptoms of conjunctivitis significantly reduced; and laboratory parameters of disease activity became normal (erythrocyte sedimentation rate, C-reactive protein concentration).After 3 months, inflammation in the coronary arteries was stopped.After 6 Incense months, a regression of coronary artery aneurysms was recorded.

No adverse effects during the immunoglobulin therapy were observed.